Dergiler / Journal of Urological Surgery / 2019 / Cilt: 6 - Sayı: 2

Can Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates Predict Bone Metastasis in Prostate Cancer Patients?

Nötrofil/Lenfosit ve Trombosit/Lenfosit Oranları Prostat Kanseri Olgularında Kemik Metastazını Öngörebilir mi?

Sayfa
105–110
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

While high NLR has been generally considered an independent risk factor for poor PCa prognosis, we assume that larger scale studies are warranted to assess its value as a prognostic indicator in PCa patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Bone metastasis is common in advanced prostate cancer (PCa).
📊
Temel Bulgular & Veri:Materials and Methods: The study group included 85 PCa patients.
💡
Sonuç & Katkı:While high NLR has been generally considered an independent risk factor for poor PCa prognosis, we assume that larger scale studies are warranted to assess its value as a prognostic indicator in PCa patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Bone metastasis is common in advanced prostate cancer (PCa). Recently, there has been a growing interest in the potential role of inflammatory markers, such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and neutrophil-to-monocyte ratio (NMR), in predicting advanced disease in patients with solid tumors. In the current study, we aimed to assess the relationship of bone metastasis detected on bone scintigraphy (BS) with NLR, PLR, and NMR in patients with Pca. Materials and Methods: The study group included 85 PCa patients. Patient characteristics, prostate-specific antigen (PSA) values, Gleason score, histopathological features, presence of metastatic focus on BS and complete blood count values were retrospectively evaluated. The relationship of the presence of bone metastasis on BS with clinicopathological features such as PSA, Gleason score, histopathological findings and NLR, PLR and NMR values were investigated. Results: Median NLR, PLR and NMR were 2.90, 125.69 and 8.38, respectively. Thirty-six patients had metastatic disease on BS. Our findings showed a statistically significant relationship between high NLR value and the presence of bone metastasis (p=0.018) and high Gleason score (p=0.034). However, no significant statistical relationship was found between clinicopathological features and PLR and NMR values (p>0.05). Conclusion: Despite the limited number of patients, a significant relationship between high NLR and metastatic bone disease was found. While high NLR has been generally considered an independent risk factor for poor PCa prognosis, we assume that larger scale studies are warranted to assess its value as a prognostic indicator in PCa patients.

Abstract

Amaç: İleri prostat kanserinde (PCa) kemik metastazı yaygın olarak görülmektedir. Son zamanlarda, solid tümörlerde ilerlemiş hastalığın öngörülmesinde nötrofil lenfosit oranı (NLR), trombosit lenfosit oranı (PLR) ve nötrofil monosit oranı (NMR) gibi enflamatuvar belirteçlerin potansiyel rolüne olan ilgi artmıştır. Bu çalışmada, PCa’da kemik sintigrafisinde (KS) saptanan kemik metastazları ile NLR, PLR ve NMR arasındaki ilişkiyi değerlendirmeyi amaçladık. Gereç ve Yöntem: Çalışma grubunu 85 PCa hastası oluşturdu. Hastaların özellikleri, prostat spesifik antijen (PSA) değerleri, Gleason skoru, histopatolojik özellikleri, KS’de metastatik odak varlığı ve tam kan sayımı retrospektif olarak incelendi. KS’de kemik metastazı varlığı, PSA, Gleason skoru, histopatolojik bulgular gibi klinikopatolojik özellikler ile NLR, PLR ve NMR değerleri arasındaki ilişki araştırıldı. Bulgular: Medyan NLR, PLR ve NMR sırasıyla 2,90, 125,69 ve 8,38 idi. Otuz altı hastada KS’de metastatik hastalık vardı. Bulgularımız yüksek NLR değeri ile kemik metastazı varlığı (p=0.018) ve yüksek Gleason skoru arasında istatistiksel olarak anlamlı bir ilişki olduğunu gösterdi (p=0,034). Ancak PLR ve NMR ile klinikopatolojik özellikler arasında anlamlı istatistiksel ilişki bulunamadı (p>0,05). Sonuç: Sınırlı hasta sayısına rağmen, yüksek NLR ve metastatik kemik hastalığı arasında anlamlı ilişki bulundu. NLR genel olarak prostat kanseri prognozu için bağımsız bir risk faktörü olarak kabul edilirken, bu hasta grubunda prognostik bir belirteç olarak kabul edilmesi için daha kapsamlı çalışmaların yapılmasının gerekli olduğunu düşünüyoruz.

🔖

Bu Makaleye Atıf Yap

CEYLAN, Y., TATLIDİL, S., ŞEN, S., SARSIK, B., ÖZCAN, Z. (2019). Can Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates Predict Bone Metastasis in Prostate Cancer Patients?. Journal of Urological Surgery, Cilt: 6 - Sayı: 2, 105–110. https://ajindex.com/articles/189967

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860
  2. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The Systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 2013;88:218-230
  3. Luo Y, She DL, Xiong H, Fu SJ, Yang L. Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2015;94:e1670
  4. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer related inflammation. Nature 2008;454:436-444
  5. Stock D, Groome PA, Siemens DR. Inflammation and prostate cancer: A future target for prevention and therapy. Urol Clin North Am 2008;35:117- 130
  6. Sciarra A, Gentilucci A, Salciccia S, Pierella F, Del Bianco F, Gentile V, Silvestri I, Cattarino S. Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review. J Inflamm (Lond) 2016;13:35
  7. Parikh S, Murray L, Kenning L, Bottomley D, Din O, Dixit S, Ferguson C, Handforth C, Joseph L, Mokhtar D, White L, Wright G, Henry AM. Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate Cancer. Clin Oncol (R Coll Radiol) 2018;30:548-555
  8. National Cancer Institute. SEER Cancer Stat Facts: prostate cancer. 2017
  9. Grivennikov SI, Greten FR, Karin M. Cell Immunity, Inflammation and Cancer. Cell 2010;140:883-899
  10. Kawahara T, Fukui S, Sakamaki K, Ito Y, Ito H, Kobayashi N, Izumi K, Yokomizo Y, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Yao M, Miyamoto H, Uemura H. Neutrophil-to lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy. Oncotarget 2015;6:32169-32176
  11. Wang J, Liu Y, Zhang N, Li X, Xin P, Bi J, Kong C. Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer. Oncotarget 2017;8:70874-70882
  12. Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer 2011;11:64
  13. Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, Ellis IO, Green AR. Tumor-infiltrating CD8+lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011;29:1949-1955
  14. Luo Y, She DL, Xiong H, Fu SJ, Yang L. Pretreatment neutrophil to lymphocyte ratio as a prognostic predictor of